About Palmatum

Palmatum is a public limited company (NV/SA) based in Gent, founded in 2025. Its main activity is classified as "Handel in eigen onroerend goed". For the 2025 financial year, Palmatum reported a loss of €24,204. Revenue was not published, which is common for abbreviated accounts. The gross margin came to €185,313. Equity stands at €75,796, a solvency ratio of 0.5%.

Juridical situation
Normal situation
Company number
1022.176.102
Founding date
Founded on 09-04-2025
EUID number
BEKBOBCE.1022.176.102
Type of enterprise
Rechtspersoon
Location
Esplanade Oscar Van De Voorde 1 Gent 9000
Juridical form
NV — Public limited company (NV/SA)
Activities
Signals
Reporting losses
Poor liquidity
High debt
Positive cashflow
Positive EBITDA

Financial ratios

Profit
€ -24K
Equity
€ 76K
Gross margin
€ 185K
Health
Solvability > 25%
0.5%
Liquidity > 1.0
0.25
Profitability > 0%
-31.9%
2025
Gross margin
€ 185K
EBITDA
€ 185K
Profit
€ -24K
Equity
€ 76K
Solvability
0.54%
Debt
€ 13.92M
Cash
€ 217K

Frequently asked questions

Answers to the most common questions about Palmatum, based on official government data and the filed annual accounts.

What is the VAT number of Palmatum?

The VAT number of Palmatum is BE1022.176.102.

When was Palmatum established?

Palmatum was founded in 09-04-2025.

What is the official address of Palmatum?

The official address of Palmatum is Esplanade Oscar Van De Voorde 1 Gent 9000.

What is the legal form of Palmatum?

The juridical form of Palmatum is Public limited company (NV/SA).

What is the annual revenue of Palmatum?

The 2025 accounts of Palmatum do not report revenue. Smaller companies that file abbreviated accounts are not required to publish it.

Is Palmatum a reliable company?

Palmatum is a registered Rechtspersoon with company number 1022.176.102 and can be verified through the official CBE database.

What is the credit limit of Palmatum?

The estimated credit limit of Palmatum is €133,317.

Is Palmatum still active?

Palmatum currently has the status "Normal situation" and is active.

Further reading

View all insights

Sources